July 27, 2022 Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications in the U.S. read more
April 22, 2022 Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis read more
March 1, 2022 Quanterix links up with Eli Lilly for Alzheimer’s blood biomarker testing collaboration read more
December 22, 2021 2022 forecast: Blood test breakthroughs set to move the needle in Alzheimer’s, Parkinson’s research read more
October 31, 2022 Ultrasensitive Detection of Neurofilament Light Assesses the Neurological Impact of Cardiac Surgery read more